Loading clinical trials...
Loading clinical trials...
The purpose of this study is to measure the prevalence and severity of cardiac autonomic neuropathy (CAN), diabetic autonomic neuropathy (DAN) which in non-diabetics is termed advanced nervous system ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Alabama at Birmingham
NCT07168421 · Perioperative Myocardial Injury, Autonomic Dysfunction, and more
NCT07196397 · Vasovagal Syndrome VVS, Cardioinhibitory Carotid Sinus Syndrome CSS, and more
NCT05989763 · Systemic Sclerosis, Constipation, and more
NCT06857994 · Peripheral Diabetic Neuropathy, Cardiovascular Autonomic Neuropathy, and more
NCT03953768 · Autoimmune Diseases, Epilepsy, and more
Callahan Eye Foundation Hospital
Birmingham, Alabama
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions